A DAD’S feet went so numb he felt like he was “walking in flippers”. Mart Roe, 62, was dismissed as having a virus by doctors ...

To be able to say out loud “actually this is really tough” doesn’t change the situation, but it helps us accept the gravity ...

The 62-year-old woke up with a very sore back one morning in August, starting off as a ‘niggly’ pain. This soon turned into a ‘horrendous’ sharp, stabbing pain, so he booked in with a chiropractor in ...

A father whose feet were so numb he felt like he was "walking in flippers" before an incurable blood cancer diagnosis has ...

In 2025, the American Cancer Society estimates that 36,110 new cases of multiple myeloma will be diagnosed, affecting about 20,030 men and 16,080 women. Who gets multiple myeloma?

Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, ...

Multiple myeloma is almost always preceded by an asymptomatic premalignant stage known as monoclonal gammopathy of undetermined significance (MGUS). About 1% of patients with MGUS progress to SMM ...

Panelists discuss how emerging therapies like CAR T cells and bispecific antibodies may transform frontline treatment by potentially replacing transplant or changing induction regimens, while ...

Panelists discuss the emotional and diagnostic journey of a multiple myeloma patient and his care partner, highlighting how ...

Regeneron Pharmaceuticals has received accelerated FDA approval for Lynozyfic, a new bispecific antibody treatment for adults with relapsed or refractory multiple myeloma who have undergone at least ...